-
Ferring Pharmaceuticals and Enteris BioPharma Enter License Agreement to Develop an Oral Formulation of a Peptide-based Injectable Therapeutic
-Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced today that the companies have entered…
0 -
Ferring partners with Intralytix to develop bacteriophage treatments for conditions associated with the microbiome and drug-resistant bacteria
-Ferring Pharmaceuticals is partnering with Intralytix, Inc to develop and commercialise bacteriophage-based treatments…
Archive for January, 2017
2017 > January